SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006900
Filing Date
2024-03-07
Accepted
2024-03-07 08:30:14
Documents
15
Period of Report
2024-03-07
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240305_8k.htm   iXBRL 8-K 23129
  Complete submission text file 0001437749-24-006900.txt   161697

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240307.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240307_def.xml EX-101.DEF 12187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240307_lab.xml EX-101.LAB 16396
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240307_pre.xml EX-101.PRE 12457
16 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240305_8k_htm.xml XML 3057
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 24728237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)